期刊文献+

布地奈德吸入治疗毛细支气管炎临床观察 被引量:6

Clinical observation of budesonide inhalation in treatment of bronchiolitis
下载PDF
导出
摘要 目的探讨布地奈德雾化吸入治疗毛细支气管炎的临床疗效。方法对2010年1月至2011年12月收住的100例毛细支气管炎随机分为治疗组与对照组,每组为50例。2组基本治疗相同,治疗组给予布地奈德雾化吸入;对照组给予地塞米松静脉滴注。比较2组患儿临床症状体征改善情况及住院时间。结果与对照组相比,治疗组患儿咳嗽、气促、喘息、肺部哮鸣音或湿啰音消失时间明显缩短,住院时间减少,差异有统计学意义(P<0.05);治疗组总有效率为96%,对照组总有效率为82%,差异有统计学意义(P<0.05)。结论布地奈德吸入治疗毛细支气管炎起效快,效果肯定,缩短住院时间。 Objective To study the clinical effect of nebulized budesonide inhalation in the treatment of bronchiolitis. Methods The 100 cases of infants with bronchiolitis admitted to this hospital from 2010 January to 2011 December were randomly divided into treatment group and control group, with 50 cases in each group. The basic therapy of the two groups were the same, The treatment group were treated with nebulized budesonide inhalation; the control group was given intravenous dexamethasone. Clinical symptoms and signs to improve and the time in hospital of two groups of children were compared. Results Compared with control group, the time of cough, wheezing, shortness of breath, pulmonary wheeze or wet rale in the treatment group were reduced. The hospitalization time was shortened, and the difference was statistically significant (P 〈 0.05 ). The total effective rate in treatment group and control group was 96% and 82%, respectively, and the difference was statistically significant (P 〈 0.05 ). Conclusion Budesonide inhalation in the treatment of bronchiolitis shows fast action on- set, affirmative effect, and shortened time of hospitalization.
作者 章礼真
出处 《安徽医学》 2012年第7期858-859,共2页 Anhui Medical Journal
关键词 布地奈德 毛细支气管炎 雾化吸入 疗效 Budesonide Bronchiolitis Aerosol inhalation Curative effect
  • 相关文献

参考文献5

二级参考文献24

  • 1邵洁,A.Purohit,石学耕,俞善昌,邓伟吾,F.de Blay.哮喘患者全血在尘螨主要过敏原刺激下辅助性T淋巴细胞1/辅助性T淋巴细胞2细胞内细胞因子的表达与偏移[J].上海医学,2005,28(8):637-639. 被引量:12
  • 2胡亚美,江载芳.诸富棠实用儿科学.7版.北京:人民卫生出版社,2003:1199.
  • 3陈育智,赵京.儿童支气管哮喘的诊断及治疗.北京:人民卫生出版社,2003:154.
  • 4中华医学会耳鼻咽喉科分会 中华耳鼻咽喉科杂志编委会.AR诊断标准及疗效评定标准(1997年修订海口)[J].中华耳鼻咽喉科杂志,1998,:134-135.
  • 5Seavuzzo MC,Recehi V,Fattori B,et al.Cytokine secretion in nasalmucus of normal subjects and patients with allergic rhinitis.Biomed Pharmacother,2003,57(8):366-371.
  • 6Daley Yates PT,Baker RC.Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.Clin Pharmacol,2001,51(1):103-105.
  • 7Erin EM,Zacharasiewicz AS,Nicholson GC,et al.Topical corticosteroid inhibits interleukin-4,-5 and -13 in nasal secretions following allergen challenge.Clin Exp Allergy,2005,35(12):1608-1614.
  • 8Fitz GM. Aeute asthma[J].BMJ,2001,323:841.
  • 9NAEPP Report. Expert panel report:Guidelines for the diagnosis and management of Asthma Update on Selected Topics - 2002 [ J ]. J Allergy Clin Immunol , 110 : 141.
  • 10Noppen M. Magnesium treatment for asthrna[J ]. Chest, 2002,122- 397.

共引文献44

同被引文献60

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部